Research highlights

Nanomedicine

Volumn 6, Issue 2, 2011, Pages 311-312

  Mi, Yu ^a   Liu, Yutao ^a   Guo, Yajun ^b,c   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c National Engineering Research Center for Antibody Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NANOCARRIER; TRASTUZUMAB;

BINDING AFFINITY; BREAST CANCER; CANCER INVASION; CELL PROLIFERATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG TARGETING; GENE OVEREXPRESSION; IMMUNOTHERAPY; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79952582979     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.11.1     Document Type: Note

References (1)

1. National Cancer Institute: Dictionary of Cancer Terms-Maximum tolerated dose www.cancer.gov/dictionary/CdrID-= 546597